Family History Isn't the Whole Story: What Black Women Should Know About Genetic Risk for Breast Cancer

Published: July 26th, 2026

By Just Listen to Us (JL2US)

Looking Beyond Family History

When many people think about breast cancer risk, they often ask one question: "Does anyone in my family have breast cancer?" While family history is an important part of understanding risk, it is not the only factor. In fact, most women diagnosed with breast cancer have no known family history of the disease. Age, lifestyle, environmental exposures, reproductive history, genetics, and chance all contribute to an individual's risk.

As genetic medicine continues to evolve, healthcare providers have more tools than ever to identify women who may benefit from earlier screening, enhanced surveillance, or preventive strategies. For Black women, understanding these advances is especially important, as they continue to experience significant disparities in breast cancer outcomes.

Understanding Hereditary Breast Cancer

According to the CDC, approximately 5% to 10% of all breast cancers are considered hereditary, meaning they are caused by inherited genetic mutations passed from one generation to the next. The remaining 90% to 95% develop for reasons that are often more complex and involve a combination of genetic, environmental, hormonal, and lifestyle factors.

The two most well-known genes associated with hereditary breast cancer are BRCA1 and BRCA2. Everyone is born with these genes, and under normal circumstances, they help repair damaged DNA and suppress tumor growth. However, when harmful mutations occur, the body's ability to repair damaged cells can be impaired, increasing the lifetime risk of breast and ovarian cancers.

Today, genetic testing has expanded beyond BRCA1 and BRCA2. Many healthcare providers now use multigene panels that evaluate additional genes—including PALB2, CHEK2, ATM, TP53, and others—that may also increase cancer risk and help guide individualized care.

Why This Matters for Black Women

The NHI states, that although breast cancer incidence among Black and White women is now similar overall, Black women remain approximately 38% to 40% more likely to die from the disease. NHI further details, Black women also tend to be diagnosed at younger ages than White women and are disproportionately affected by triple-negative breast cancer (TNBC), an aggressive subtype that accounts for about 10% to 15% of all breast cancers but occurs more frequently in African American women. These differences contribute to persistent disparities in survival and underscore the importance of early detection, individualized assessment (Tyrer-Cuzick (IBIS) Breast Cancer Risk Evaluation Tool), and equitable access to high-quality care. 

Differences in access to high-quality healthcare, delays in diagnosis, barriers to screening, underrepresentation in clinical research, socioeconomic factors, environmental exposures, and structural inequities all contribute to differences in outcomes. Understanding hereditary risk is one important piece of a much larger conversation about health equity.

More Than BRCA: The Importance of Genetic Counseling

Genetic testing is not recommended for everyone, but it may be appropriate for women who:

• Were diagnosed with breast cancer at a young age.

• Have multiple relatives with breast, ovarian, pancreatic, or prostate cancer.

• Have a known BRCA or other inherited mutation in the family.

• Have been diagnosed with triple-negative breast cancer at a younger age.

• Have a family history of male breast cancer.

A genetic counselor can review your personal and family history, explain the benefits and limitations of testing, and help determine whether testing is appropriate.

Importantly, a positive genetic test does not mean someone will definitely develop cancer, just as a negative test does not eliminate all risk. Instead, genetic information helps patients and healthcare providers make more informed decisions about screening, prevention, and treatment.

Understanding Breast Cancer Risk Assessment

Genetic testing is only one tool used to evaluate breast cancer risk. Healthcare providers often use validated breast cancer risk assessment models, such as the Tyrer-Cuzick (IBIS) Risk Model, to estimate a woman's likelihood of developing breast cancer over the next 10 years and throughout her lifetime.

Unlike genetic testing alone, these models evaluate multiple factors that contribute to risk, recognizing that breast cancer is influenced by genetics, personal health history, reproductive factors, and lifestyle. Depending on the model used, healthcare providers may consider:

• Age

• Race and ethnicity (where applicable)

• Age at first menstrual period

• Age at first live birth

• Menopausal status

• Height and weight (Body Mass Index)

• Personal history of breast biopsies or atypical breast lesions

• Family history of breast, ovarian, pancreatic, and prostate cancers

• The ages at which relatives were diagnosed

• Whether relatives have known BRCA or other inherited genetic mutations

• Breast density (for models that incorporate mammographic findings)

• Previous genetic testing results

• Hormone replacement therapy use (in some models)

The Tyrer-Cuzick model is among the most widely used tools because it combines family history with personal health and reproductive factors to provide a more comprehensive estimate of breast cancer risk. The results can help guide decisions about when to begin screening, whether supplemental imaging such as breast MRI and/or ultrasound may be appropriate, whether referral to a genetic counselor is recommended, and whether additional preventive strategies should be considered.

For Black women, comprehensive risk assessments are especially important. Researchers continue to evaluate how well existing prediction models perform across diverse populations, highlighting the need for continued research and validation to ensure every woman receives the most accurate assessment possible. As precision medicine evolves, improving these tools for historically underrepresented populations remains an important step toward achieving greater health equity.

Why JL2US Is Following This Story

At Just Listen to Us (JL2US), we believe knowledge empowers prevention. Understanding hereditary breast cancer is not about creating fear—it is about giving Black women access to information that can support earlier detection, informed decision-making, and more personalized healthcare. True progress, however, requires ensuring that Black women are not only included in research but also have equitable access to genetic counseling, personalized risk assessments, high-quality screening, and the latest medical innovations. Every woman deserves the opportunity to understand her individual risk and make informed decisions about her health.

JL2US will continue following emerging research that helps close health disparities and empowers Black women with trusted, evidence-based health information.

References & Further Reading

• National Cancer Institute. BRCA Gene Changes: Cancer Risk and Genetic Testing.

• Centers for Disease Control and Prevention. Hereditary Breast and Ovarian Cancer.

• American Cancer Society. Breast Cancer Facts & Figures.

• American Society of Clinical Oncology. Genetic Testing for Hereditary Cancer Risk.

• Tyrer J, Duffy SW, Cuzick J. A Breast Cancer Prediction Model Incorporating Familial and Personal Risk Factors (IBIS/Tyrer-Cuzick Model).